Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies, Pyrosequencing in Cross-Licensing Deal

NEW YORK, March 12 -- Genetic Technologies of Melbourne, Australia, and Pyrosequencing of Uppsala, Sweden, today announced a cross-licensing agreement the two companies are valuing at $2.5 million.


Pyrosequencing will pay Genetic Technologies a fee of $500,000 and royalties for a non-exclusive license to Genetic Technologies' non-coding DNA analysis and mapping patents. Genetic Technologies will install three Pyrosequencing instruments in Australia, and gain access to intellectual property for use in Australia and New Zealand.


The companies will collaborate to develop gene-based assays based on the Pyrosequencing platform.


In a statement, the companies said that cash payments, instruments, reagents, assay design services, intellectual property and royalties is estimated to be worth $2.5 million.


Genetic Technologies will apply the technology to its genetics diagnostics business, and its cacncer-susceptibility testing facility being established in Melbourne.



The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.